Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • WATSON PHARMACEUTICALS INC Financial Overview

  • Income Statement: WPI

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 2.54 B 2.50 B 38.85 M 1.53%
    Gross Profit 980.04 M 815.49 M 164.55 M 16.79%
    Net Income Before Extra Items/Preferred Div 238.38 M 141.03 M 97.35 M 40.84%
    Operating Income 388.88 M 315.84 M 73.03 M 18.78%
  • Cash Flow: WPI

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -20.17 M -312.50 M 292.33 M -1,449.12%
    Net Cash Flow - Investing 93.36 M 64.29 M 29.06 M 31.13%
    Net Cash Flow/Operating Activities 416.55 M 427.18 M -10.62 M -2.55%
  • Balance Sheet: WPI

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 3.63 B 3.41 B 215.48 M 5.94%
    Total Liabilities 1.52 B 1.56 B -43.64 M -2.88%
    Shareholders Equity 2.11 B 1.85 B 259.12 M 12.29%
  • Key Ratios / Statistics: WPI

    • Valuation

      Price/Earnings (TTM) 12.71
      Price/Sales (TTM) 1.23
      Price/Book (MRQ) 1.59
      Price/Cash Flow (TTM) 9.10
    • Profitability

      Gross Margin 38.65
      Operating Margin 15.34
      Profit Margin 9.40
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.71
      Current Ratio (MRQ) 4.30
      Long Term Debt-to-Equity (MRQ) 43.17
    • Management Effectiveness

      Return on Equity (TTM) 10.35
      Return on Assets (TTM) 6.36
      Return on Investments (TTM) 8.94